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In respect of the manifold involvement of lipids in biochemical processes, the analysis of intact and underivatised lipids of body
ﬂuids as well as cell and tissue extracts is still a challenging task, if detailed molecular information is required. Therefore, the
advantage of combined use of high-pressure liquid chromatography (HPLC), mass spectrometry (MS), and nuclear magnetic
resonance (NMR) spectroscopy will be shown analyzing three diﬀerent types of extracts of the ubiquitous membrane component
phosphatidylcholine. At ﬁrst, diﬀerent reversed phase modiﬁcations were tested on phosphatidylcholines (PC) with the same
eﬀective carbon number (ECN) for their applicability in lipid analysis. The results were taken to improve the separation of three
natural PC extract types and a new reversed phase (RP)-HPLC method was developed. The individual species were characterized
by one- and two-dimensional NMR and positive or negative ion mode quadrupole time of ﬂight (q-TOF)-MS as well as MS/MS
techniques. Furthermore, ion suppression eﬀects during electrospray ionisation (ESI), diﬃculties, limits, and advantages of the
individual analytical techniques are addressed.
1.Introduction
The analysis of native and underivatized lipids within body
ﬂuids as well as cell and tissue extracts is still a challenging
task, in particular, if the molecular structure of individual
components needs to be identiﬁed in decently short time.
The lipid composition consists of diﬀerent main classes such
as fatty acids, neutral lipids, and lipids with positively or
negatively charged head groups with manifold subclasses of
structural diversity. Variations within the lipid composition
were attributed to diﬀerent pathologies such as neoplastic
and neurodegenerative diseases, diabetes mellitus, and many
others. Furthermore, some lipid classes are involved in cell
death (apoptosis, necrosis), cellular signaling and are precur-
sors for lysophospholipids (i.e., lysophosphatidylcholine),
diacylglycerols, and phosphatic and arachidonic acid [1–25].
1,2-Diacyl-sn-glycero-3-phosphatidylcholine (PC) rep-
resents a major constituent of cell membranes. It consists of
the polar head group phosphorylcholine attached to the sn-3
position of glycerol and diﬀering saturated and unsaturated
fatty acids esteriﬁed to the sn-1 and sn-2 position, whereby
fatty acids in position sn-1 are preferentially saturated as a
rule. Numerous studies dealt with PCs in the past because of
their utmost biochemical and clinical importance and many
diﬀerent analytical techniques have been proposed to get an
insightintometabolicturnoverortocharacterizepathophys-
iological deviations of the native lipid composition. Most
of these techniques suﬀer from various drawbacks as being
time-consuming, insensitive, destructive, or not related to
individual substructures. Gas chromatography (GC) [26–
28], thin layer chromatography (TLC) [29–31], and high-
performance liquid chromatography (HPLC) [32–37]a r e
commonly used for lipid analysis. GC-based techniques are
quantitativebutrequiretime-consumingsamplepreparation
techniques. GC is often used in combination with TLC for
the lipid class separation. The spots on a TLC plate are2 Journal of Biomedicine and Biotechnology
scratched out and their fatty acid residues are analyzed upon
derivatization into a volatile substrate and recorded by GC.
However, the precise molecular structure of an individual
lipid is lost because of the preceding hydrolysis of the lipids.
Enzymatic cleavage of the ester bond using phospholipases
allows a successive hydrolysis of the sn-2 and sn-1 fatty acid,
but it is rather time-consuming due to intense laboratory
work and already minor contamination of the enzyme leads
to false results. HPLC oﬀers the separation of lipid classes
using the normal phase mode (NP) and additionally the
separation according to the diﬀerent fatty acid residues of an
individuallipidinthereversedphasemode(RP).Inthiscase,
a successful separation depends distinctly on the appropriate
selection of the stationary phase. Alternatively, MS-based
techniques are widely used, as they are fast, sensitive and
require only minor sample preparation [38]. The use of
high resolution MS systems give access to the molecular
formula. In addition, characteristic fragmentations identify
the lipid class and molecular structure. When coupled with
a HPLC-system their selectivity is much higher and beneﬁts
from both techniques. NMR spectroscopy is capable to
measure intact biomaterials nondestructively without any
preceding derivatization. Especially 31P-NMR is well-suited
to quantify phospholipid class analysis and needs only less
sample preparation [39–44]. Again only minor information
is obtained with respect to the fatty acid residues. 1H-
NMR measurements are also widely used, as they contain
more information about the fatty acids in general, but
the connection to the glycerol backbone is missing due to
massive signal overlap. 2D-NMR involving the 13C nucleus
provides a lot more resolution and more information about
individual species, but the low NMR sensitivity of the 13C
isotope prevents a fast and wide application of this technique
in a routine analysis [44–48].
This paper presents an eﬃcient RP-HPLC setup to sepa-
rate phosphatidylcholines, which ultimately will be extend-
able to separate other polar phospholipids. Subsequently
the HPLC tool is combined with the highly informative
molecular assignment potentials of MS and NMR [49]. Five
diﬀerent types of silica-based reversed phase modiﬁcations
were tested with respect to their capability to separate lipids
containing fatty acids with an equivalent carbon number
(ECN), which is the number of carbon atoms within a fatty
acid chain minus twice the number of double bonds. The
extension of a lipid by a C=Cd o u b l eb o n dw i l ln o tc h a n g e
the hydrophobicity. The performance of all columns was
tested on a mixture of ﬁve PCs with the same ECN whereas
two of them are even constitutional isomers concerning the
1,2-positions of glycerol, which hampers the separation even
more.
Then, the HPLC column with best performance was
used to achieve an eﬃcient baseline separation of three
native PC extracts (soy bean, bovine brain, and egg yolk).
Furthermore, the MS fragmentation behavior in the positive
and negative ion mode is investigated for individual PCs to
identify characteristic fragmentation patterns for this lipid
class and its fatty acid residues. 1D and 2D high-resolution
NMR spectra were also acquired to conﬁrm the molecular
structure.
2.MaterialandMethods
2.1. Chemicals. Methanol-d4 and deuterated chloroform,
methanol (LC-MS grade), all fatty acids, the test mixture
compounds dipalmitoyl-phosphatidylcholine (DPPC), pal-
mitoyl-oleoyl-phosphatidylcholine (POPC), oleoyl-palmi-
toyl-phosphatidylcholine (OPPC), dioleoyl-phosphatidyl-
choline (DOPC), stearoyl-linoleoyl-phosphatidylcholine
(SLPC), and also the soy bean, bovine brain, and egg yolk
extracts were purchased from Sigma-Aldrich Chemie GmbH
(Taufkirchen, Germany). The double distilled water was
taken from the in-house system.
2.2. High-Performance Liquid Chromatography. A HP 1100
series HPLC system (Agilent Technologies, Waldbronn,
Germany) was used. The injection volume was 3μL of the
standard prepared in methanol. Five columns with diﬀerent
stationary phases were tested with respect to their separation
performance for lipid analysis:
(1) type A silica-based endcapped C18 (Nucleosil 100-5
C18, 250 × 3mm),
(2) type A silica-based phenyl (Nucleosil 100-5 C6H5,
250 × 4mm),
(3) type B silica-based high density C18 (Nucleodur C18
Gravity, 5μm, 250 × 3mm),
(4) type B silica-based polymer/cross linked C18 (Nucle-
odur C18 Isis, 5μm, 250 × 3mm),
(5) type B silica-based mixed mode phenyl/C18 (Nucleo-
dur Sphinx RP, 5μm, 250 × 3mm).
All HPLC columns and materials were a kind gift of
Macherey-Nagel (D¨ uren, Germany).
The 3mm columns were operated at ﬂow rate of
0.6mL/min and the 4mm column at 1mL/min. The mobile
phase was optimized by adapting the methanol content in
diﬀerent runs between 90% and 100% for the alkyl phases
and between 80% and 100% for the phenyl phase with
respect to the hydrophobic interaction of the analytes with
the RP packing.
An 8mm Nucleodur Sphinx RP was operated under
isocratic conditions at 4.1mL/min ﬂow with a mobile phase
consisting of methanol and water (90:10) for the semi
preparative approach. To collect the individual species for
NMR measurements a Gilson 215 liquid handler (Gilson
International B.V., Bad Camberg, Germany) was used. The
column temperature was kept at 40◦Ci na l lr u n s .
2.3. Mass Spectrometry. An esquire LC iontrap system
(Bruker Daltonik GmbH, Bremen, Germany) was used for
mass spectrometric detection for positive and negative ion
m o d em a s sa n dM S / M Ss p e c t r ao fe a c hP Cc o m p o u n dw e r e
recorded. The capillary voltage was set to −3800V and the
end plate oﬀset to 500V in positive ion mode. For the HPLC
the nebulizer gas was set to 40psi, dry gas and dry heat were
set to 10L/min and 300◦C, respectively. In case of direct
infusion via a syringe pump, the dry and nebulizer gases
were reduced to 5L/min and 5psi, respectively. The collisionJournal of Biomedicine and Biotechnology 3
energy for MS/MS experiments was optimized with respect
to the precursor ion stability.
AmicrOTOF-Q-equippedwiththeApolloESIionsource
(Bruker Daltonik GmbH, Bremen, Germany) was used for
precision mass detection. The capillary voltage was set to
4500V and the end plate oﬀset to −500V in negative ion
mode. The nebulizer gas was set to 0.4bar, dry gas and dry
heat were set to 4L/min and 200◦C, respectively. For MS/MS
experiments the collision energy of the quadrupole was
−42eV/z.Themolecularformulawasgeneratedbymatching
high mass accuracy and isotopic pattern (SigmaFit, Bruker
Daltonik GmbH, Bremen, Germany).
2.4. Nuclear Magnetic Resonance. All samples were stored
at −80◦C before the measurements. In case of dissolved
samples, the solvents were evaporated by a gentle stream
of nitrogen and redissolved in CDCl3/C D 3OD (2:1). 1D
(1H, 13C) and high-resolution 2D (HSQC, HSQC-TOCSY,
HMBC) NMR spectra with a digital resolution of 1k data
points in F1 and 4k data point in F2 dimension of each
PC species were acquired on a Bruker DRX 600MHz
NMR spectrometer equipped with 5mm TXI probe (Bruker
BioSpin GmbH, Rheinstetten/Karlsruhe, Germany).
3. Results
3.1. High-Performance Liquid Chromatography. Ac o m p a r -
ison of ﬁve diﬀerent reversed phase columns revealed the
following behavior: The separation of the test mixture on
type A silica-based materials showed only poor results for
all PC compounds. Although, it seems that the Nucleosil
m a t e r i a ls e p a r a t e sa l lp e a k sv e r yw e l l( s e eTable 1), the
extreme peak broadening and a distinct tailing spoils the
pretended peak separation. In contrast, the type B silica
based materials separated DPPC, DOPC, SLPC, and POPC
or OPPC very well. However, the two lipid isomers POPC
andOPPCwere only wellseparated (Table 1) on the polymer
cross link RP packing (ISIS). With all RP materials it was
possible to separate lipids containing two monounsaturated
fatty acids from lipids with one or two saturated or one
polyunsaturated fatty acid. The shortest separation times
with sharp chromatographic peaks were achieved by the
mixed mode stationary phase (Sphinx). Therefore, this
stationary phase was selected to separate the individual
compounds within the lipid extracts of natural sources.
3.1.1. Separation of the Phosphatidylcholine Extracts. The
mixed mode stationary phase (Sphinx) and mobile phase
of 90% methanol and 10% water allows the baseline
separation of all species within the three diﬀerent extracts
(i.e., extraction residues). The separation of the PC species is
not inﬂuenced by the type or contaminations of the extract.
T h er e s u l t sa r el i s t e di nTable 2.
Altogether,twelvePCcomponentsandoneplasmalogene
(bovinebrainextract)wereidentiﬁed.Allspeciescontaineda
saturated fatty acid in position sn-1 (i.e., myristic (1 species),
palmitic (7 species) or stearic acid (4 species). Palmitic or
stearic acid were esteriﬁed to the sn-2 position within three
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Figure 1: Variation of the fragmentation energy of negative ion
mode ESI-MS2 of POPC (744.4).
compounds. The other nine compounds contained a mono-
(four times) or polyunsaturated fatty acid (ﬁve times) in
position sn-2. The plasmalogen consists of octadecanol (sn-
1) and oleic acid (sn-2). Most species were identiﬁed in
bovine brain extract (11 + 1) and the fewest in the egg yolk
extract (8).
3.1.2. Preparation of the Individual Compounds for NMR
Measurement. The same mobile phase (90% methanol and
10% water) and column type (MN Sphinx) were used
for the semipreparative HPLC runs as for the analytical
measurements. However, the HPLC column dimension was
upscaled (8mm instead of 3mm). The ﬂow was splitted after
the column and a small amount was used for peak detection
andidentiﬁcationintothemicro-TOF-Q.Theresidualeluent
was collected for NMR measurements.
3.2. Mass Spectrometry. The ionization eﬃciencies of all
equimolar concentrated saturated fatty acids were recorded
relative to the internal standard undecanoic acid in diﬀerent
measurements using the negative ESI ion mode. The ion
counts of undecanoic acid were set to 100 percent in all
cases and the ion counts of all other fatty acids were
recalculated with respect to this value (Table 3). All fatty
acids with a shorter chain length as the internal standard
show lower ionization eﬃciencies and all fatty acids with 12
or more carbon atoms show higher ionization eﬃciencies.
The ionization eﬃciency of the fatty acids increases not
linearly.
3.2.1. Fragmentation. The positive ion mode MS spectra
showed better signal to noise ratios than in the negative
ion mode. In positive ion mode, the base peak results from
the adsorption of a sodium ion. In negative ion mode, the
base peak results from the demethylation of the parent ion
during the transfer into the ion trap mass spectrometer.
[M + A]−, whereby A is chloride or formate, was observed
to a small extent only. In positive ion mode, MS/MS the
polar headgroup of phosphorylcholine was cleaved oﬀ.I n
negative ion mode, MS/MS spectra the fatty acids of each4 Journal of Biomedicine and Biotechnology
Table 1: Retention times of diﬀerent PC-components with the same ECN on diﬀerent reversed phase columns.
Lipid Column type
Nucleosil 100-5 C6H5 Nucleosil 100-5 C18 Nucleodur C18 Gravity Nucleodur Sphinx RP Nucleodur C18 Isis
DPPC 1.46 (5.76)∗ 56.82 78.00 14.31 49.19
OPPC 1.52 (6.49)∗ 59.27 86.00 16.26 51.81
POPC 1.52 (6.48)∗ 57.36 86.00 16.26 52.19
DOPC 1.64 (7.30)∗ 57.18 98.67 19.11 56.40
SLPC 1.64 (7.58)∗ 69.95 107.00 19.66 60.81
∗mobile phase methanol/water (80:20).
Table 2: Identiﬁed PC compounds within extracts of bovine brain, egg yolk, and soy bean.
Fatty acid position ECN Bovine brain Egg yolk Soy bean
sn-1 position sn-2 position
Myristic acid(14:0) Palmitic acid (16:0) 30 + − +
Palmitic acid (16:0) Palmitoleic acid (16:1) 30 + + +
Palmitic acid (16:0) Linoleic acid (18:2) 30 + + +
Palmitic acid (16:0) Linolenic acid (18:3) 28 − + −
Palmitic acid (16:0) Arachidonic acid (20:4) 28 + + +
Palmitic acid (16:0) Palmitic acid (16:0) 32 + + +
Palmitic acid (16:0) Oleic acid (18:1) 32 + + +
Stearic acid (18:0) Linoleic acid (18:2) 32 + + +
Stearic acid (18:0) Arachidonic acid (20:4) 30 + − +
C18:0 Plasmalogen Oleic acid (18:1) 34 + −−
Palmitic acid (16:0) Stearic acid (18:0) 34 + −−
Stearic acid (18:0) Oleic acid (18:1) 34 + + +
Stearic acid (18:0) Eicosenoic acid (20:1) 36 + −−
Table 3: Electrospray ionization eﬃciency of diﬀerent fatty acid
compared to undecanoic acid (pKs = 4,69 for all acids).
Fatty acid Number of
carbons
Empirical
formula
Ionisation
eﬃciency∗ (%)
caprylic acid 8C 8H16O2 52
capric acid 10 C10H20O2 64
undecanoic acid 11 C11H22O2 100
lauric acid 12 C12H24O2 131
myristic acid 14 C14H28O2 194
palmitic acid 16 C16H32O2 285
stearic acid 18 C18H36O2 609
eicosanoic acid 20 C20H40O2 2300
∗compared to undecanoic acid.
PC were assigned by detection of their [M − H]− ion
accompanied by a neutral loss of the fatty acid ketene. The
sn-2 fatty acid of every PC species shows always the more
intense signal compared to the sn-1 fatty acid signal. Figure 1
shows several overlaid MS/MS iontrap spectra of POPC, but
with increasing fragmentation energy to show the energy
dependence of the diﬀerent fragment ions. Table 4 lists the
individual observed fragments and their corresponding m/z
values.
3.2.2.IdentiﬁcationofthePhosphatidylcholinesintheDiﬀerent
Extracts. Negative ion mode MS and auto-MS/MS q-TOF
spectra were recorded during the HPLC runs. The fatty
acid residues of each individual PC component was assigned
by its relative fragment ion intensities. Furthermore, the
molecular formula of each detected ion was generated
by matching high mass accuracy and isotopic pattern to
conﬁrm the results. The lipid class was conﬁrmed by the
molecular formula and reconstructing the precursor ion
of the fragment ions. Table 2 shows the indentiﬁed species
within the three diﬀerent extracts.
3.3. Nuclear Magnetic Resonance. 1D-(1Ha n d13C) and 2D-
(HSQC, HSQC-TOCSY, and HMBC) NMR spectra of the
ﬁve reference PCs were recorded for peak assignment. The
NMR parameters of all reference compounds are listed
in the supplements. Lipids with saturated (DPPC), mono
unsaturated fatty acids (MOFA) as in POPC, OPPC, DOPC,
or polyunsaturated fatty acids (PUFA) as in SLPC show zero,
two or four carbon signals between 120 and 130ppm. The
MOFA and PUFA show unambiguously diﬀerent chemical
shifts for the oleﬁnic carbons; however, the three lipids
with MOFAs have nearly identical oleﬁnic carbon shifts
respectively the distance between the double bond signals
depends on the MOFA location (sn-1 or sn-2). Figure 2Journal of Biomedicine and Biotechnology 5
Table 4: Assignment of the individual observed fragments of POPC.
Fragment Assignment m/z
Ap a l m i t i c a c i d [ M − H]− 255.0
B oleic acid [M − H]− 281.0
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Figure 2:Overlaid 13C-NMRspectralsectionsofoleﬁniccarbonsof
PCs with MOFAs (top OPPC, middle POPC, and bottom DOPC).
shows the overlaid 13C NMR spectra of POPC, OPPC, and
DOPC. The chemical shift diﬀerence between these two
signals is about 50Hz for POPC and about 47Hz for OPPC.
The corresponding 1H-NMR spectra show identical signals
for the oleﬁnic protons (not shown). Nonetheless, a lipid
with two MOFAs can be deduced from the intensity ratio of
the oleﬁnic protons to the glycerol protons in the 1H-NMR
spectra.
3.3.1. NMR of the PC Extracts. HPLC-MS structural results
were conﬁrmed for all molecular species using 1D-(1H) and
2D-(HSQC, HSQC-TOCSY, and HMBC) NMR techniques.
The results are shown in Table 2. No branched chain or
oxidized fatty acids were observed. The NMR parameter of
unsaturated fatty acids have been measured separately (see
Supplement) and are identical within the mixtures.
4. Discussion
Lipids with equal ECN should have the same hydropho-
bicity, which is the discriminating factor in reversed phase
chromatography. This holds for PCs with the same ECN
within a mixture and even more, if they are stereoisomers
such as POPC and OPPC. The successful reversed phase
separation of hydrophobic and zwitterionic molecules like
phosphatidylcholines depends on very well endcapped silica
materials, as Coulomb interactions of the choline group6 Journal of Biomedicine and Biotechnology
with the silica gel lead to peak broadening, retention time
shifts (data not shown), and peak tailing. Packing materials
with hydrophobic van der Waals interactions only (i.e., high
densityC18materials)shownoseparationofisomericlipids.
Additional interactions like steric eﬀects by polymer cross-
linked RP packings can overcome this problem. Stationary
phases with only aromatic modiﬁcations are not hydropho-
bic enough to achieve a good phospholipid separation. The
mixed mode stationary phase contains additionally alkyl
ligands and oﬀers therefore more hydrophobic interactions
and good silica gel coverage. This column showed the
shortest phospholipid retention times for all alkyl stationary
phases and a good separation with narrow chromatographic
peaks. Saturated lipids have the lowest and polyunsaturated
lipids the highest retention times. Comparing lipids of the
same ECN with two MOFAs or one PUFA and one saturated
fattyacidtheretentionofthelipidwiththePUFAishigher,as
their spatial demand is larger and the π-π interactions with a
PUFA residue is not aﬀected by the other fatty acid.
4.1. Separation of the Phosphatidylcholine Extracts. By means
of the HPLC separation it was possible to get semiquan-
titative information of the individual compounds in the
extracts. Referring to the results of the separation of the
lipid standard mixture it was possible to separate all species
within the extracts. The elution order of lipids with the same
ECN is in the same line as for the reference mixture (lipids
with saturated fatty acids, one MOFA, two MOFAs, one
PUFA). However, in case of PUFAs with four double bonds
(i.e., arachidonic acid; 20:4) the π-π interactions become
so strong that this compound elutes as last compound
in the next higher ECN group (see Table 2). Nonetheless,
they are unambiguously identiﬁed by means of their MS
fragmentation or NMR spectra.
4.2. Preparation of the Individual Compounds for NMR
Measurement. The upscaling with the same type of RP
packing of the newest generation is no problem, although
a peak broadening can occur because of the higher sample
load.
4.3. Ion Suppression Eﬀects. The ionization eﬃciency of the
diﬀerent fatty acids during ESI increases nonlinearly. The
results can be correlated with the molecules hydrophobicity,
which shows the same progression. The hydrophobicity
is obtained from the octanol-water partitioning coeﬃcient
(log pow) (data not shown). There are no diﬀerences between
the pKa values of the individual fatty acids (Table 3), so
that the ionization eﬃciency of the fatty acids depends only
on the molecules hydrophobicity, which increases by the
number of carbon atoms.
As POPC and OPPC or SLPC and DOPC, respectively,
have the same molecular weight/precision mass, they cannot
be assigned based on their mol peak only. However, they
are distinguished by MS/MS spectra, as the sn-2 fatty acid
is always cleaved oﬀ at lower fragmentation energies due to
sterical eﬀects. In addition, the intensity ratio of the sn-2
fatty acid anion to the sn-1 fatty acid anion is constant
for a particular fragmentation energy. A semiquantitative
or even quantitative analysis of stereoisomeric PCs within
a mixture (f.e., POPC and OPPC) still is diﬃcult, because
the anion signal of an individual fatty acid will be the same
regardless the position on the glycerol backbone and no
otherdistinguishingsignalisobservedforoneoftheisomers.
However,usingtheintensityratioofthesn-2fattyacidanion
to the sn-1 fatty acid anion for the pure reference compound
one can calculate the approximate POPC to OPPC ratio.
The MS detection limits also beneﬁts from the isocratic
HPLC method with high-organic solvent concentration in
the mobile phase. In case of gradient HPLC, methods
the ionization eﬃciency varies with the varying organic
percentage of the mobile phase. Furthermore, the risk of ion
suppression during the ionization process is minimized by
the sample introduction after HPLC separation.
The identiﬁcation of the individual species in the dif-
ferent extracts was achieved by MS/MS and comparing the
individual fragment intensities as described earlier. The use
of high-resolution spectra acquired by the micro-TOF-Q
allows the generation of the compound’s molecular formula
by matching high mass accuracy and isotopic pattern.
Abnormalities like oxidation of the double bond, and so
forth. were not observed.
Itmaybenoted,thatnotonlydiacylPLscanbeidentiﬁed
within a mixture, but also alkyl/alkenyl, acyl PLs because of
the diﬀerent fragmentation pattern of the fatty acid residue
compared to an ether link.
The HPLC and MS results were conﬁrmed by NMR
spectroscopy, especially the conﬁguration and location of
double bonds in the fatty acid residues. Only NMR having
the highest qualitative and quantitative structure elucidation
potential allows a complete structure elucidation. 1H-, 13C-,
or 31P-NMR spectra are capable to identify the various lipid
classes. Beyond this, the degree of unsaturation is obtained
from the proton signal intensity ratio of the double bond
signal versus the choline group signal. MOFAs and PUFAs
are diﬀerentiated by the number of carbon signals within
the double bond region. The location (sn-1 or sn-2) of the
MOFA follows from the 13C-NMR spectra or from ESI-MS.
TheriskofpeakoverlappingintheNMRspectrawasavoided
by recording 2D-NMR spectra by preceding separation of
individual phosphatidylcholines by HPLC.
5. Conclusion
The separation of lipids with equivalent chain lengths in
complexmixturescanbeimprovedusingRP-HPLCpackings
of the newer generation containing additional discrimina-
tors. Already simple PC mixture cannot be assigned by
a single analytical technique, while the combination of
HPLC separation power, MS sensitivity with accurate mass
measurement of molecular and fragment ions and NMR
structure elucidation power will meet most suitably the
challenge. They overcome the limits of any single technique
and also proof the potential of their combination ultimately
to analyze native (lipid) mixtures. The molecular structure
of a novel compound may not be evaluated by NMR alone,Journal of Biomedicine and Biotechnology 7
if the native concentration is very low. Conversely, MS data
may give molecular weight, fragmentation and molecular
formulae that may be insuﬃcient to assign ambiguously the
molecular structure of an unknown compound. However,
online NMR and MS detections in parallel provide comple-
mentarydataandminimizeambiguitiesbetweenLC-MSand
LC-NMR systems very eﬃciently.
Combination of these data allows the identiﬁcation of
a lipid class, reconstruction of the lipid structure, and both
the location of an individual fatty acid to the sn-1 or sn-2
positionintheglycerolmoietyorthelocationofdoublebond
within the fatty acid chains.
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